JPMORGAN CHASE & CO - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$15,351,952
-3.9%
171,377
-8.7%
0.00%0.0%
Q2 2023$15,978,905
+8.5%
187,678
+5.5%
0.00%0.0%
Q1 2023$14,721,000
+122076.1%
177,891
+16.1%
0.00%0.0%
Q4 2022$12,049
-99.9%
153,205
+4.6%
0.00%0.0%
Q3 2022$10,842,000
+23.6%
146,453
+8.8%
0.00%
+100.0%
Q2 2022$8,774,000
+2.7%
134,625
-0.3%
0.00%0.0%
Q1 2022$8,540,000
+47.6%
135,079
+23.9%
0.00%0.0%
Q4 2021$5,784,000
-27.6%
109,062
-3.6%
0.00%0.0%
Q3 2021$7,989,000
-5.3%
113,153
-10.6%
0.00%0.0%
Q2 2021$8,434,000
-26.4%
126,557
+22.6%
0.00%
-50.0%
Q1 2021$11,459,000
+2.4%
103,217
+9.5%
0.00%0.0%
Q4 2020$11,190,000
+46.0%
94,229
+6.8%
0.00%
+100.0%
Q3 2020$7,662,000
+40.9%
88,219
+45.3%
0.00%0.0%
Q2 2020$5,439,000
-40.9%
60,728
-34.2%
0.00%
-50.0%
Q1 2020$9,204,000
-63.9%
92,348
-58.4%
0.00%
-60.0%
Q4 2019$25,495,000
-29.4%
221,893
-22.5%
0.01%
-28.6%
Q3 2019$36,102,000
+96.6%
286,200
+86.0%
0.01%
+75.0%
Q2 2019$18,361,000
-8.2%
153,908
-32.7%
0.00%0.0%
Q1 2019$20,010,000
-28.9%
228,732
-18.7%
0.00%
-42.9%
Q4 2018$28,158,000
-65.4%
281,435
-60.4%
0.01%
-56.2%
Q3 2018$81,335,000
+79.2%
709,853
+40.2%
0.02%
+77.8%
Q2 2018$45,396,000
+14.8%
506,197
-6.4%
0.01%
+12.5%
Q1 2018$39,552,000
+388.3%
540,630
+287.6%
0.01%
+300.0%
Q4 2017$8,100,000
+118.9%
139,466
+63.0%
0.00%
+100.0%
Q3 2017$3,700,000
+126.2%
85,562
+106.5%
0.00%
Q2 2017$1,636,000
-36.3%
41,434
-34.6%
0.00%
-100.0%
Q1 2017$2,570,000
-54.7%
63,344
-55.1%
0.00%0.0%
Q4 2016$5,675,000
+350.0%
141,186
+305.4%
0.00%
Q3 2016$1,261,000
+25.7%
34,825
+0.6%
0.00%
Q2 2016$1,003,000
-16.7%
34,619
+0.6%
0.00%
Q1 2016$1,204,000
+14950.0%
34,418
+13722.5%
0.00%
Q4 2015$8,000
-97.5%
249
-97.3%
0.00%
Q3 2014$322,000
-85.9%
9,221
-85.8%
0.00%
-100.0%
Q2 2014$2,285,000
+80.6%
64,737
+66.6%
0.00%
Q1 2014$1,265,000
-59.1%
38,860
-47.0%
0.00%
-100.0%
Q4 2013$3,091,000
+3.5%
73,374
-2.0%
0.00%0.0%
Q3 2013$2,987,000
-31.3%
74,896
-28.7%
0.00%0.0%
Q2 2013$4,345,000105,0810.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders